Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma to the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05889091
What this trial is testing

The Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT05608876
What this trial is testing

A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
QBiotics Group Limited 15
Early research (Phase 1)Study completedNCT01353625
What this trial is testing

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

Who this might be right for
Glioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more
Celgene 118
Testing effectiveness (Phase 2)Looking for participantsNCT06959082
What this trial is testing

Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer Squamous Cell Carcinoma
VSPharmTech Co.,Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00006245
What this trial is testing

Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT06496178
What this trial is testing

Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Merus B.V. 621
Not applicableStudy completedNCT02277548
What this trial is testing

A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck.

Who this might be right for
Oropharyngeal CancerSquamous Cell Carcinoma to the Head and Neck
Abramson Cancer Center at Penn Medicine 20
Large-scale testing (Phase 3)Ended earlyNCT00911326
What this trial is testing

Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Navidea Biopharmaceuticals 101
Testing effectiveness (Phase 2)Active Not RecruitingNCT04414540
What this trial is testing

Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Trisha Wise-Draper 21
Early research (Phase 1)Looking for participantsNCT05952947
What this trial is testing

HRYZ-T101 Injection for HPV18 Positive Solid Tumor

Who this might be right for
Cervical CancerHead and Neck Squamous Cell CarcinomaCarcinoma of Vagina+3 more
HRYZ Biotech Co. 32
Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Not applicableNot Yet RecruitingNCT07259915
What this trial is testing

Multimodal Prediction of Response to Chemoradiotherapy for Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Cancer of Head and Neck (SCCHN)
Centre Henri Becquerel 152
Testing effectiveness (Phase 2)Looking for participantsNCT07339176
What this trial is testing

Intratumoral N17350 in Advanced Solid Tumors

Who this might be right for
Neoplasms, Solid TumorBreast Neoplasms, Triple-NegativeSquamous Cell Carcinoma of Skin+4 more
Onchilles Pharma Inc 275
Testing effectiveness (Phase 2)Looking for participantsNCT05260671
What this trial is testing

Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN

Who this might be right for
Head and Neck NeoplasmsRecurrent DiseaseMetastatic Cancer
Eye & ENT Hospital of Fudan University 48
Testing effectiveness (Phase 2)Study completedNCT04997902
What this trial is testing

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Who this might be right for
HNSCC
Kura Oncology, Inc. 45
Large-scale testing (Phase 3)Ended earlyNCT00006994
What this trial is testing

S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat

Who this might be right for
Cancer-related Problem/ConditionHead and Neck CancerPain
SWOG Cancer Research Network 23
Large-scale testing (Phase 3)Ended earlyNCT04949256
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).

Who this might be right for
Metastatic Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 863
Testing effectiveness (Phase 2)Study completedNCT00445861
What this trial is testing

Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 27
Testing effectiveness (Phase 2)Looking for participantsNCT07172802
What this trial is testing

GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Cancer (NSCLC)+3 more
GI Innovation, Inc. 102
Early research (Phase 1)Study completedNCT03758781
What this trial is testing

IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors

Who this might be right for
Metastatic CancerRecurrent CancerSolid Tumor+6 more
H. Lee Moffitt Cancer Center and Research Institute 12
Next Page